Dr Alan Remaley
Disclosure details
Alan Remaley has research agreements with AstraZeneca, Hartis Pharmaceuticals and Corividia Inc.Section Chief of the Lipoprotein Metabolism Laboratory in the Cardiopulmonary Branch of the National Heart, Lung and Blood Institute, Bethesda, MD, USA
